Antibodies to Recombinant-Derived Glycoprotein B after Natural Human Cytomegalovirus Infection Correlate with Neutralizing Activity

Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

1986 • 334 citations

Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response

1990 • 316 citations

Human cytomegalovirus strain towne glycoprotein B is processed by proteolytic cleavage

1988 • 183 citations

Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus

1989 • 119 citations

Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus

1991 • 106 citations

Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus

1985 • 99 citations

Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne

1990 • 90 citations

The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope

1990 • 84 citations

Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers

1990 • 79 citations

Immune responses to isolated human cytomegalovirus envelope proteins

1986 • 54 citations

Immunoblot Analysis of the Humoral Immune Response in Primary Cytomegalovirus Infection

1988 • 51 citations

An Adenovirus Recombinant that Expresses the Human Cytomegalovirus Major Envelope Glycoprotein and Induces Neutralizing Antibodies

1990 • 48 citations

Human immune responses to major human cytomegalovirus glycoprotein complexes

1988 • 39 citations

Progress Toward Developing a Cytomegalovirus Vaccine

1990 • 9 citations

Cited By (0)

No citing papers found in database